04/30/2024
4:26 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:46 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 10-K/A | |
04/19/2024
4:10 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
9:08 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
04/18/2024
7:21 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
04/15/2024
4:22 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
4:13 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B3 | |
|
04/15/2024
5:00 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B3 | |
04/02/2024
5:01 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
4:18 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/21/2024
4:09 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
4:08 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
03/11/2024
4:16 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
02/28/2024
4:09 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
9:40 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
02/26/2024
4:15 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
02/14/2024
5:03 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
3:37 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2024
3:16 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
5:36 PM | NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
Rehnquist Janet (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form PRE 14A | |
12/29/2023
3:15 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
3:30 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K/A | |
11/22/2023
3:31 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
11/22/2023
3:32 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form ARS | |
11/21/2023
4:23 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
3:05 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
3:04 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
8:19 AM | Gorovitz Aaron (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
8:15 AM | Hurvitz Chaim (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
3:48 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/31/2023
4:18 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B3 | |
08/31/2023
4:20 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
11:14 AM | Javitt Jonathan C (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
8:24 AM | Javitt Jonathan C (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
4:10 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/28/2023
4:15 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2023
9:21 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
06/07/2023
4:18 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K/A | |
06/06/2023
3:27 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
7:00 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Biden Nomination CANCELED? (Ad) The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.”
Why is he all BUT guaranteed the Democratic nomination, in their words? I believe I have the terrifying answer right here. |
